Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how platforms are being adapted for use in later stages of drug development as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.
*Video Produced by Bioanalysis Zone
Services
Platforms